beta-alanyl-N-{4-[3-(nitrooxy)propyloxy]benzyl}-L-histidinamide

ID: ALA2047751

Chembl Id: CHEMBL2047751

PubChem CID: 66571941

Max Phase: Preclinical

Molecular Formula: C19H26N6O6

Molecular Weight: 434.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCc1ccc(OCCCO[N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C19H26N6O6/c20-7-6-18(26)24-17(10-15-12-21-13-23-15)19(27)22-11-14-2-4-16(5-3-14)30-8-1-9-31-25(28)29/h2-5,12-13,17H,1,6-11,20H2,(H,21,23)(H,22,27)(H,24,26)/t17-/m0/s1

Standard InChI Key:  YIQSAIKUOPAQOJ-KRWDZBQOSA-N

Associated Targets(Human)

Serum (1292 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thoracic aorta (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.45Molecular Weight (Monoisotopic): 434.1914AlogP: 0.08#Rotatable Bonds: 14
Polar Surface Area: 174.50Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.20CX Basic pKa: 9.12CX LogP: -0.83CX LogD: -2.59
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.18Np Likeness Score: -0.72

References

1. Bertinaria M, Rolando B, Giorgis M, Montanaro G, Marini E, Collino M, Benetti E, Daniele PG, Fruttero R, Gasco A..  (2012)  Carnosine analogues containing NO-donor substructures: synthesis, physico-chemical characterization and preliminary pharmacological profile.,  54  [PMID:22626653] [10.1016/j.ejmech.2012.04.032]

Source